Assessing a co-culture fungal granule ability to remove pharmaceuticals in a sequencing batch reactor

Biodegradation of carbamazepine (CBZ), diclofenac sodium (DCF) and ibuprofen (IBP) was evaluated through fungal granules development in a sequencing batch reactor (SBR). Fungal granules were developed in co-culture of T. polyzona, A. niger, T. longibrachiatum, M. circinelloides and R. microsporus at a retention time (RT) of 2 days and 1 day. Ligninolytic enzymes [laccase (Lac), lignin peroxidase (LiP) and manganese peroxidase (MnP)] were determined. Removal of pharmaceuticals was assessed and metabolites identified using the SPE-UPLC-QToF/MS methods. A pH range of 3-4.6 was found to improve the granulation development from day 6 and the production of ligninolytic enzymes [MnP (253.00 ± 14.19 U/L), Lac (111.58 ± 10.00 U/L) and LiP (95.25 ± 8.22 U/L)]. At steady-state, a removal of 97.41±0.25%, 99.83±0.14%, and 99.91±0.08 were achieved at an RT of 2 days for CBZ, DCF, and IBP, respectively, and of 91.94±0.05%, 99.31±0.12% and 97.72±0.23% at an RT of 1 days for the same PhCs. A variety of chemical reactions have been proposed for degradation pathways catalysed by enzyme-producing fungi, generating fragment ions of intermediate compounds. This study is highly relevant for cost-effective and environmentally friendly wastewater treatment processes in water scare countries.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:43

Enthalten in:

Environmental technology - 43(2022), 11 vom: 14. Apr., Seite 1684-1699

Sprache:

Englisch

Beteiligte Personen:

Kasonga, Teddy Kabeya [VerfasserIn]
Coetzee, Martie A A [VerfasserIn]
Kamika, Ilunga [VerfasserIn]
Momba, Maggy Ndombo Benteke [VerfasserIn]

Links:

Volltext

Themen:

33CM23913M
Carbamazepine
Diclofenac
EC 1.10.3.2
EC 1.11.1.-
Fungal granules
Ibuprofen
Journal Article
Laccase
Peroxidases
Pharmaceutical Preparations
Sequencing batch reactor
WK2XYI10QM

Anmerkungen:

Date Completed 13.04.2022

Date Revised 13.04.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/09593330.2020.1847204

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM317199501